F(2)-Dihomo-isoprostanes and brain white matter damage in stage 1 Rett syndrome.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochimie

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.biochi.2012.09.017PMID 23009927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of RhoGTPases Improves the Behavioral Phenotype and Reverses Astrocytic Deficits in a Mouse Model of Rett Syndrome

  2012cited by this paper
• Wild type microglia arrest pathology in a mouse model of Rett syndrome

  2012cited by this paper
• Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil

  2012cited by this paper
• Total Synthesis of Isoprostanes Derived from Adrenic Acid and EPA

  2012cited by this paper
• Oxidative stress in Rett syndrome: Natural history, genotype, and variants

  2011cited by this paper
• F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome

  2011cited by this paper
• Adrenoleukodystrophy.

  2011cited by this paper
• F₄-neuroprostanes mediate neurological severity in Rett syndrome.

  2011cited by this paper
• Synaptic plasticity deficits in an experimental model of rett syndrome: long-term potentiation saturation and its pharmacological reversal.

  2011cited by this paper
• A role for glia in the progression of Rett’s syndrome

  2011cited by this paper
• Metabolic oxidation regulates embryonic stem cell differentiation

  2010cited by this paper
• Rett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate

  2010cited by this paper
• White Matter Impairment in Rett Syndrome: Diffusion Tensor Imaging Study with Clinical Correlations

  2010cited by this paper
• Rett syndrome: Revised diagnostic criteria and nomenclature

  2010cited by this paper
• Lipase-catalyzed regioselective monoacetylation of unsymmetrical 1,5-primary diols.

  2010cited by this paper
• Total synthesis of 15-D(2t)- and 15-epi-15-E(2t)-isoprostanes.

  2010cited by this paper
• Rett syndrome: what do we know for sure?

  2009cited by this paper
• Systemic oxidative stress in classic Rett syndrome.

  2009cited by this paper
• Mecp2-Null Mice Provide New Neuronal Targets for Rett Syndrome

  2008cited by this paper
• Stereocontrolled access to isoprostanes via a bicyclo[3.3.0]octene framework.

  2008cited by this paper
• Secretion of brain‐derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling

  2006cited by this paper
• Differential regulation of c-jun and CREB by acrolein and 4-hydroxynonenal.

  2006cited by this paper
• Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835.

  1999cited by this paper
• Rett Syndrome: 1H Spectroscopic Imaging at 4.1 Tesla

  1999cited by this paper
• Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2

  1999cited by this paper
• Lipids of nervous tissue: composition and metabolism.

  1985influential reference
• Edinburgh Research Explorer Gene Expression Analysis Exposes Mitochondrial Abnormalities in a Mouse Model of Rett Syndrome

  year unknowncited by this paper

• Adrenic acid: A promising biomarker and therapeutic target (Review)

  2024cites this paper
• Ageing and Neurodegenerative Diseases The Role of MeCP2 in Oligodendrocyte Lineage Cells of Rett Syndrome: Review and Inference

  2023cites this paper
• Nuclear and Cytoplasmatic Players in Mitochondria-Related CNS Disorders: Chromatin Modifications and Subcellular Trafficking

  2022cites this paper
• Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation

  2021cites this paper
• Relevance of seminal F2-dihomo-IsoPs, F2-IsoPs and F4-NeuroPs in idiopathic infertility and varicocele.

  2020cites this paper
• 2,4 Dinitrophenol as Medicine

  2019cites this paper
• Increased isoprostanoid levels in brain from murine model of Krabbe disease - Relevance of isoprostanes, dihomo-isoprostanes and neuroprostanes to disease severity.

  2019cites this paper
• The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder – a review

  2019cites this paper
• MeCP2 in central nervous system glial cells: current updates.

  2018cites this paper
• Oxidative stress markers imbalance in late-life depression.

  2018cites this paper
• Dietary DHA, bioaccessibility, and neurobehavioral development in children

  2018cites this paper
• Melatonin and hydroxytyrosol protect against oxidative stress related to the central nervous system after the ingestion of three types of wine by healthy volunteers.

  2017cites this paper
• MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome

  2017cites this paper
• Insight into the contribution of isoprostanoids to the health effects of omega 3 PUFAs.

  2017cites this paper
• Two sides of the same coin: NEO‐PUFAs in Rett syndrome and post‐infarction cardiac arrhythmias

  2017cites this paper
• Antiepileptic drugs affect lipid oxidative markers- neuroprostanes and F2-dihomo-isoprostanes- in patients with epilepsy: differences among first-, second-, and third-generation drugs by UHPLC-QqQ-MS/MS

  2016cites this paper
• Assessment of oxidative stress biomarkers – neuroprostanes and dihomo-isoprostanes – in the urine of elite triathletes after two weeks of moderate-altitude training

  2016cites this paper
• Lipidomic approach in young adult triathletes: effect of supplementation with a polyphenols-rich juice on neuroprostane and F2-dihomo-isoprostane markers.

  2016cites this paper
• Assessment of Isoprostanes in Human Plasma: Technical Considerations and the Use of Mass Spectrometry

  2016cites this paper
• Oxidative stress and cognition amongst adults without dementia or stroke: Implications for mechanistic and therapeutic research in psychiatric disorders.

  2015cites this paper
• Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: protective effect of CNF1.

  2015cites this paper
• Dihomo-isoprostanes-nonenzymatic metabolites of AdA-are higher in epileptic patients compared to healthy individuals by a new ultrahigh pressure liquid chromatography-triple quadrupole-tandem mass spectrometry method.

  2015cites this paper
• Oxidative Stress and BDNF as Putative Biomarkers of Cognitive Flexibility in Adolescent Bipolar Disorder

  2015cites this paper
• The isoprostanes--25 years later.

  2015cites this paper
• Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome

  2014cites this paper
• Effects of ω-3 PUFAs Supplementation on Myocardial Function and Oxidative Stress Markers in Typical Rett Syndrome

  2014cites this paper
• Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence.

  2014cites this paper
• Inflammatory Lung Disease in Rett Syndrome

  2014cites this paper
• Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.

  2014cites this paper
• ROS and Brain Diseases: The Good, the Bad, and the Ugly

  2013cites this paper
• Fatty Acids and Autism Spectrum Disorders: The Rett Syndrome Conundrum

  2013cites this paper